US OK’s first-in-class drug Aimovig for migraine prevention
Amgen and Novartis' Aimovig has become the first anti-CGRP therapy to win regulatory clearance in the US, winning approval for migraine prevention. [...]
Fri, May 18, 2018
International Clinical Researcher of the Year - Winners announced
The 19th International Clinical Researcher of the Year took place at the Millennium Gloucester Hotel in London's Kensington last night, hosted by BBC news presenters Charlie Stayt and Ros Atkins. [...]
Fri, May 18, 2018
Janssen pulls plug on Alzheimer’s candidate
Safety concerns have prompted Janssen to pull the plug on a development programme testing the BACE inhibitor atabecestat for Alzheimer's disease. [...]
Fri, May 18, 2018
Trials show benefit of ‘on demand’ use of AZ’ asthma inhaler
AstraZeneca has unveiled data from two Phase III trials showing the benefit of using Symbicort Turbuhaler as an anti-inflammatory reliever ‘as needed' versus two different treatment regimens in patients with mild asthma. [...]
Fri, May 18, 2018

 

The Learning  Partnership